Neuroimaging of Escitalopram in Autism Spectrum Disorder

PHASE2Enrolling by invitationINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 28, 2025

Primary Completion Date

December 30, 2025

Study Completion Date

December 30, 2025

Conditions

Autism Spectrum Disorder

Interventions

DRUG

Escitalopram 10mg

oral administration of escitalopram 10 mg

DRUG

Placebo

Trial Locations (1)

Hoglund Biomedical Imaging Center, Kansas City

All Listed Sponsors

lead

Kathryn Unruh

OTHER